Alexandria Real Estate Equities was among the participants as the drug discovery technology provider closed its series C round.

US-based drug discovery platform provider Alloy Therapeutics has completed a $75m series C round that included Alexandria Venture Investments, the venture capital arm of life sciences real estate investment trust Alexandria Real Estate Equities. VC firms 8VC and Presight Capital co-led the round with entrepreneur Peter Thiel, and it also featured Founders Fund, Gaingels, Mubadala…

The rest of this content is only accessible to Corporate Venturing: News, Data, and Events - Global Corporate Venturing Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.